Baltimore, Md. — The Program for Neurology Research and Discovery was well-represented at the 2018 Peripheral Nerve Society Annual Meeting, which was held July 21-25 at Renaissance Baltimore Harborplace Hotel. Drs. Eva Feldman, Rodica Pop-Busui, Brian Callaghan, Phillipe O’Brien and Stephanie Eid were specifically engaged with the Diabetic Neuropathy Consortium.
Dr. Feldman was the chair for the moderated panel debate “Neurophysiology Endpoint Talks (EMG, QST, Autonomic).” Following an introduction from Dr. Pop-Busui, Dr. Feldman spoke about “Perspective on Endpoints.”
Dr. Pop-Busui also provided introductions for “What’s New in Diabetic and Non-diabetic Lumbosacral Radiculoplexus Neuropathy (DLRPN)” and “What’s New in Treatment-Induced Neuropathy of Diabetes (TIND).”
Dr. Callaghan had a pair of talks, which were entitled “Metabolic Syndrome Components and Neurologic Outcomes in a Bariatric Surgery Population,” and “Diabetic Peripheral Neuropathy
and the Opioid Crisis.”
Dr. O’Brien delivered a talk on “Caloric Restriction in BKS Db/db Mice does not Ameliorate Diabetic Peripheral Neuropathy,” while also co-chairing an oral poster session.
Dr. Eid spoke about “The Emerging Role of NOX5 in Diabetic Neuropathy: A New Answer to an Old Question,” and then co-chaired oral poster presentations.